Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165  334 patients between 2009 and 2015 in France

Pharmacoepidemiology and Drug Safety, EarlyView.

Source: Pharmacoepidemiology and Drug Safety - September 25, 2018 Category: Drugs & Pharmacology Authors: Christophe Chaignot, Mahmoud Zureik, Gr égoire Rey, Rosemary Dray‐Spira, Joël Coste, Alain Weill Source Type: research